-

Johnson Fistel Continues Investigation on Behalf of DexCom, Inc. Shareholders

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc. (NASDAQ: DXCM) for potential breaches of fiduciary duties and violations of the federal securities laws.

What is Johnson Fistel Investigating? Between April 28, 2023 and June 5, 2024, certain DexCom insiders caused the company to issue false and misleading public statements regarding its expansion strategy and purported market share. However, beginning on April 25, 2024, DexCom made its first in a series of public corrective disclosures announcing that the company’s growth and business prospects were far lower than it had previously claimed. By the time the company made its final corrective disclosure on July 25, 2024, the price of DexCom’s shares had plummeted by over 40.6%.

Current stockholders who held their DexCom stock before April 28, 2023, are encouraged to contact Johnson Fistel to discuss their legal rights in this matter. You can click or copy and paste the following link to join this investigation: https://www.johnsonfistel.com/investigations/dexcom-inc-2

About Johnson Fistel, PLLP:

Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.

Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Contacts

Johnson Fistel, PLLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

Industry:

Johnson Fistel, PLLP

NASDAQ:DXCM
Release Versions
English

Contacts

Johnson Fistel, PLLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

More News From Johnson Fistel, PLLP

Johnson Fistel Investigates Hims & Hers Regulatory Evasion and Investor Impact

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP announces that it is investigating potential claims on behalf of investors of Hims & Hers Health, Inc. (NYSE: HIMS) regarding possible violations of federal securities laws. Investors who purchased Hims & Hers securities may be eligible to recover losses stemming from alleged misrepresentations and omissions made by the company and its executives. What if I purchased Hims & Hers securities? If you incurred significant losses and want...

Johnson Fistel Launches Probe into Skechers Go Private Deal

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a leading shareholder rights law firm, has commenced an investigation into whether the board of directors of Skechers U.S.A., Inc. (NYSE: SKX) breached its fiduciary duties in connection with the proposed sale of the Company to 3G Capital Corp. (“3G”). The inquiry focuses on the fairness of the consideration being offered to Skechers’ public shareholders and whether the transaction reflects full and fair value for all shareholders. On May 5, 202...

Johnson Fistel Continues Investigation on Behalf of SentinelOne, Inc. Shareholders

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating claims on behalf of SentinelOne, Inc. (NYSE: S) against certain of its officers and directors. If you are a current, long-term shareholder of SentinelOne, continuously holding shares since June 1, 2022, you may have standing to hold the company harmless from the alleged harm caused by the Company's officers and directors by making them personally responsible. You may also be able to assist in reforming the Company's corporate gov...
Back to Newsroom